enfr+33 (0)5 17 81 07 63contact@meccellis.com



Press release – November 14th, 2023. More information on our LinkedIn page :
Group Ph Tech (Meccellis Biotech, Apha Biomat) is delighted to announce that we’ve raised €5m in Series B funding, led by the continued participation of Océan Participations with the participations of new investors Volney Développement, Synergence BA and co-investor Fonds NACO (M CAPITAL).

Alongside with Bpifrance, Région Nouvelle-Aquitaine, Territoires d’industrie, European Union, the support of all investors will allow us to offer innovative solutions for tomorrow’s surgeries.

This financing round is also supported by the future development of Meccellis Biotech on US market, leading to a total operation of €8m.

This is a major milestone for our rapidly growing Group Ph Tech, and a signal to the market that Apha Biomat‘s medical devices will soon be available.

We are honoured by the presence of PIERRICK CHARROT, FABIEN POIRIER, AMAURY CAMBON, GILLES GANTOIS in Ph Tech’s board.


Barcelona Breast Meeting

Barcelona Breast Meeting – Hospital Sant Pau
March 22nd – 24th, 2023

Reconstructive and Aesthetic Breast Surgery.

London Breast Meeting

London – Royal College of Physicians
September 08th – 10th, 2022

News in Oncological, Reconstructive and Aesthetic Breast Surgery.

Looking for new partners

Meccellis Biotech
March 16th, 2022

Meccellis biotech is looking for new partners to distribute our biological matrix for Breast reconstruction, Cellis® Breast.

© 2023 Meccellis. All right reserved.